Skip to main content

  • Bivalirudin versus unfractionated heparin in peripheral vascular interventions

    • Posted: 10/01/2018
    • Author:

      Jad Omran, Tariq Enezate, Obai Abdullah, Ashraf S. Al-Dadah, Herbert D. Aronow, Jihad Mustapha, Fadi Saab, Emmanouil S. Brilakis, Ryan R. Reeves, Deepak L. Bhatt and Ehtisham Mahmud

    • 2019CRM

    Abstract

    Background

    A number of studies suggest that bivalirudin (BIV) is associated with similar efficacy but reduced bleeding when compared with unfractionated heparin (UFH) in patients undergoing peripheral vascular interventions (PVI).

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details